Tags : pancrelipase

AbbVie to Divest Allergan’s Brazikumab and Zenpep (pancrelipase) to Gain

Shots: Allergan will divest its brazikumab to AstraZeneca including its global development and commercialization rights while Nestle to acquire complete ownership of Zenpep and will be acquiring Viokace as a part of the same transaction The divestiture of two therapies is in conjunction with the ongoing US FTC’s and EC’s approval. The transactions are expected […]Read More